Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of adipose tissue-derived stromal cells in treating premature ovarian failure

A technology for stem cells and ovarian function, which is applied in the application field of adipose-derived mesenchymal stem cell drugs in the treatment of premature ovarian failure, can solve the problems of increasing the risk of venous blood clots, ovarian cancer and breast cancer, and achieves strong practicability and controllability High, the effect of promoting functional ovulation

Active Publication Date: 2018-04-24
深圳市莱利赛生物科技有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

One of the most common treatments for premature ovarian failure in women is hormone replacement therapy (HRT), but HRT can increase the risk of blood clots in the veins and ovarian and breast cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] An application of adipose-derived mesenchymal stem cell medicine in the treatment of premature ovarian failure, wherein the adipose-derived mesenchymal stem cell medicine comprises: 8% fat-derived mesenchymal stem cells, 6% follicle-stimulating hormone-secreting cells, 20% magnetic nanometer buffer Release microspheres, 4% human albumin stock solution, 5% coix seed oil, 1% flavonol glycosides, 1% vitamin E, 0.5% paclitaxel, 0.4% glutathione, 0.5% sodium hyaluronate, 0.3% algae Penicillin, 0.4% zinc gluconate, 0.5% heparin calcium, 0.5% emulsifier, 0.5% stabilizer, 0.3% PH regulator, the rest is normal saline, magnetic nano-sustained-release microspheres have a high loading rate, and can release drugs slowly It is effective, and contains magnetism, with stronger targeting; human serum albumin stock solution can provide a suitable microenvironment for adipose-derived mesenchymal stem cells and follicle-stimulating hormone-secreting cells, and improve cell activity; coix se...

Embodiment 2

[0036] An application of a fat-derived mesenchymal stem cell medicine in the treatment of premature ovarian failure. The fat-derived mesenchymal stem cell medicine includes: 10% fat-derived mesenchymal stem cells, 7% follicle-stimulating hormone-secreting cells, 21% magnetic nanometer slow Release microspheres, 5% human albumin stock solution, 6% coix seed oil, 1.2% flavonol glycosides, 1.5% vitamin E, 0.8% paclitaxel, 0.6% glutathione, 1% sodium hyaluronate, 0.9% algae Penicillin, 1.2% zinc gluconate, 0.6% heparin calcium, 0.7% emulsifier, 0.8% stabilizer, 0.4% PH regulator, the balance is normal saline, magnetic nano-sustained-release microspheres have a high loading rate, and can release drugs slowly It is effective, and contains magnetism, with stronger targeting; human serum albumin stock solution can provide a suitable microenvironment for adipose-derived mesenchymal stem cells and follicle-stimulating hormone-secreting cells, and improve cell activity; coix seed oil has ...

Embodiment 3

[0049] An application of adipose-derived mesenchymal stem cell medicine in the treatment of premature ovarian failure, wherein the adipose-derived mesenchymal stem cell medicine comprises: 12% fat-derived mesenchymal stem cells, 8% follicle-stimulating hormone-secreting cells, 22% magnetic nanometer buffer Release microspheres, 6% human albumin stock solution, 7% coix seed oil, 1.5% flavonol glycosides, 2% vitamin E, 1% paclitaxel, 0.8% glutathione, 1.5% sodium hyaluronate, 1.2% algae Penicillin, 1.8% zinc gluconate, 0.8% heparin calcium, 1% emulsifier, 1% stabilizer, 0.5% PH regulator, the rest is normal saline, magnetic nano-sustained-release microspheres have a high loading rate, and can release drugs slowly It is effective, and contains magnetism, with stronger targeting; human serum albumin stock solution can provide a suitable microenvironment for adipose-derived mesenchymal stem cells and follicle-stimulating hormone-secreting cells, and improve cell activity; coix seed ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of adipose tissue-derived stromal cells in treating premature ovarian failure, and belongs to the technical field of a biological medicine. Adipose tissue-derived stromal cells and its excreted cell factors, and other components at a certain ratio are applied to form adipose tissue-derived stromal cells; then the adipose tissue-derived stromal cells are prepared to be injection fluid and a drug patch; the injection fluid is injected to the zone where a focus locates through a local target injection method, and then the patch is pasted to a patient's navel; through an electromagnetic impulse generator, a drug is intermittently stimulated, and the secretion of follicle-stimulating hormone is promoted, ovary endometrium can be effectively repaired, the functional ovulation is promoted, and premature ovarian failure is effectively treated. In short, the application has the advantages of being safe and effective, higher in controllability and strong inpracticability.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to the application of a fat-derived mesenchymal stem cell drug in the treatment of premature ovarian failure. Background technique [0002] Premature ovarian failure (POF), also known as hyperhormonal hypogonadism, refers to the occurrence of amenorrhea for 4-6 months in women before the age of 40. L) is associated with low estrogen secretion. POF can lead to loss of fertility and can also be linked to medical problems such as blood clots, osteoporosis, and heart disease. [0003] The causes of POF are complex. Some patients have ovarian abnormalities due to genetic diseases, such as fragile X (chromosome) syndrome, Turner syndrome, and certain autosomal gene mutations. Some cases of POF may be the result of an autoimmune disease. Chemotherapy and radiation therapy for cancer can also cause ovarian failure. There are two basic types of premature ovarian failure: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/28A61K38/38A61P15/08C12N5/0775C12N5/071A61K35/12A61K31/7048A61K31/785A61K31/315A61K38/06A61K36/8994A61K31/728A61K31/727A61K31/355A61K31/337
CPCA61K31/337A61K31/355A61K31/7048A61K31/727A61K31/728A61K31/785A61K33/30A61K35/12A61K35/28A61K36/8994A61K38/06A61K38/385C12N5/0667C12N5/0682C12N2506/1384A61K2300/00
Inventor 宋芸娟胡士庶张治国
Owner 深圳市莱利赛生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com